Does pulmonary rehabilitation give additional benefit over tiotropium therapy in primary care management of chronic obstructive pulmonary disease? Randomized controlled clinical trial in Hong Kong Chinese

Journal of Clinical Pharmacy and Therapeutics

Volumn 30, Issue 6, 2005, Pages 567-573

  Lindsay, M ^a   Lee, A ^a,c   Chan, K ^a   Poon, P ^b   Han, L K ^b   Wong, W C W ^a   Wong, S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Hong Kong Society for Rehabilitation   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chronic obstructive pulmonary disease; Hong Kong; Primary care; Pulmonary rehabilitation; Randomized controlled trial; Tiotropium

Indexed keywords

TIOTROPIUM BROMIDE; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE DERIVATIVE; TIOTROPIUM;

ADULT; AGED; ARTICLE; CHINESE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GOLD STANDARD; HONG KONG; HUMAN; MALE; PRIMARY MEDICAL CARE; PULMONARY REHABILITATION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; VISUAL ANALOG SCALE; WALKING; HEALTH BEHAVIOR; KINESIOTHERAPY; PSYCHOLOGICAL ASPECT;

AGED; BRONCHODILATOR AGENTS; CHOLINERGIC ANTAGONISTS; EXERCISE THERAPY; FEMALE; HEALTH BEHAVIOR; HONG KONG; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SCOPOLAMINE DERIVATIVES; SPIROMETRY;

EID: 33644979327     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2005.00686.x     Document Type: Article

References (32)

1. Soriano JB, Maier WC, Egger P et al. (2000) Recent trends in physician diagnosed COPD in women and men in the UK. Thorax, 55, 789 794.
2. Office for National Statistics (2000) Mortality statistics: cause, 1999. DH2 (No 26).
3. National Collaborating Centre for Chronic Conditions (2003) Management of adults with chronic obstructive pulmonary disease in primary and secondary care London: National Institute for Clinical Excellence.
4. Lee A, Lau FL, Hazlett CB et al. (2001) Analysis of the morbidity pattern of non-urgent patients attending accident and emergency departments in Hong Kong. Hong Kong Medical Journal, 7, 311 318.
5. Pauwels RA, Lofdahl CG, Laitinen LA et al. (1999) Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society study on chronic obstructive pulmonary disease. New England Journal of Medicine, 340, 1948 1953.
6. Vestbo J, Sorensen T, Lange P, Brix A, Torre P, Viskum K (1999) Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet, 353, 1819 1823.
7. Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK (2000) Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. British Medical Journal, 320, 1297 1303.
8. Strijbos JH, Postma DS, van Altena R, Gimeno F, Koeter GH (1996) A comparison between an outpatient hospital-based pulmonary rehabilitation program and a home-care pulmonary rehabilitation program in patients with COPD: a follow-up of 18 months. Chest, 109, 366 372.
9. Guell R, Casan P, Belda J et al. (2000) Long-term effects of outpatient rehabilitation of COPD: a randomized trial. Chest, 117, 976 983.
10. American Thoracic Society (1999) Pulmonary rehabilitation-1999. American Journal of Respiratory and Critical Care Medicine, 159, 1666 1682.
11. MacNee W, Calverley PMA (2003) Chronic obstructive pulmonary disease. 7: Management of COPD. Thorax, 58, 261 265.
12. Global Initiative for Chronic Obstructive Lung Disease (2003) Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. http://www.goldcopd.com
13. Lorig KR, Sobel DS, Stewart AL et al. (1999) Evidence suggesting that a chronic condition disease self management programme can improve health status while reducing hospitalisation: a randomised trial. Medical Care, 37, 5 14.
14. Ries AL, Kaplan RM, Limberg TM, Prewitt LM (1995) Effect of pulmonary rehabilitation on physiological and psychological outcomes in patients with chronic obstructive pulmonary diseases. Annals of Internal Medicine, 122, 823 832.
15. Disse B, Speck GA, Rominger KL, Witek TJ, Hammer R (1999) Tiotropium (Sprivia TM): mechanisitcal considerations and clinical profile in obstructive lung disease. Life Science, 64, 457 464.
16. Littner MR, Ilowite JS, Tashkin DP et al. (2000) Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 161, 1136 1142.
17. Vincken W, Van Noord JA, Greefhorst APM et al. (2002) Improved health outcomes in patients with COPD during 1 year's treatment with tiotropium. European Respiratory Journal, 19, 209 216.
18. Casaburi R, Mahler DA, Jones PW et al. (2002) A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. European Respiratory Journal, 19, 217 224.
19. Brusasco V, Hodder R, Miravitles M, Korducki L, Towse L, Kesten S (2003) Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax, 58, 399 404.
20. Donohue JF, van Noord JA, Bateman ED et al. (2002) A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest, 122, 47 55.
21. British Thoracic Society (1997) BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax, 52 (5S 1S 28S.
22. de Torres JP, Pinto-Plata V, Ingenito ED et al. (2002) Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest, 121, 1092 1098.
23. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW (1987) A measure of quality-of-life for clinical-trials in chronic lung-disease. Thorax, 42, 773 778.
24. Guyatt GH, Pugsley SQ, Sullivan MJ et al. (1984) Effect of encouragement on walking test performance. Thorax, 39, 818 822.
25. Jones R, Copper S, Dobbs F (1999) A pilot study of short pulmonary rehabilitation in general practice. Thorax, 54 (Suppl. 3 A62.
26. National Institute for Clinical Excellence (2004) CG12 Chronic obstructive pulmonary disease: NICE guideline London: National Institute for Clinical Excellence.
27. Janelli LM, Scherer YK, Schmieder LE (1991) Can a pulmonary health teaching programme alter patients' ability to cope with COPD? Rehabilitation Nursing, 16, 199 202.
28. Toshima MT, Kaplan RM, Ries AL (1990) Experimental evaluation of rehabilitation in chronic obstructive pulmonary disease: short term effects on exercise endurance and health status. Health Psychology, 9, 237 252.
29. Fabbri LM, Hurd SS, for the GOLD Scientific Committee (2003) Global strategy for the diagnosis, management, and prevention of COPD 2003 update. European Respiratory Journal, 22, 1 2.
30. The Lung Health Study Research Group (2000) Effect of inhaled triamcinolone on the decline in pulmonary function in chronic pulmonary disease. New England Journal of Medicine, 343, 1902 1909.
31. Jones PW, Willits LR, Burge PS, Calverley PM (2003) Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations. European Respiratory Journal, 21, 68 73.
32. Szafranski W, Cukier A, Ramirez A et al. (2003) Efficacy and safety of budesonide/formoterol in management of chronic obstructive pulmonary disease. European Respiratory Journal, 21, 74 81.